The Fast-Tracked Ebola Vaccine

Who We Are

Why we created this site

Merck has received the FDA’s fast-tracked approval of a live, genetically modified Ebola vaccine which, according to the vaccine insert, can cause a novel new form of Ebola-type infection, resulting in immunosuppression and possible shedding of the live virus to others.

The vaccine insert also states:

Transmission of vaccine virus is a theoretical possibility. Vaccine virus RNA has been detected in blood, saliva, or urine for up to 14 days after vaccination.

The duration of shedding is not known; however, samples taken 28 days after vaccination tested negative. Vaccine virus RNA has been detected in fluid from skin vesicles that appeared after vaccination.

How can this be? What are they really trying to do? More coming soon…

text text text

Be the first to comment

Leave a Reply

Your email address will not be published.


*